News

Is Cannabis the Antibiotics of the 21st Century?

Is Cannabis the Antibiotics of the 21st Century?

25 July, 2021

Prof. Doron Steinberg, a researcher and lecturer from the Faculty of Dental Medicine and the Director of the Biofilm Research Lab, says that modern microbiology is not designed to kill viruses but rather to attack the biofilm construction.  In his lab, basic research is combined with clinical applications for a variety of developments and innovations to help combat biofilm as a major cause for infectious diseases like fungal diseases and Cystic Fibrosis that he is currently researching. “My goal is to think of additional applicable applications for cannabinoids, and the possibilities are endless.”

Understanding the Impact of Medical Marijuana on Children, a Meta-Analysis / Ilan Matok

Understanding the Impact of Medical Marijuana on Children, a Meta-Analysis / Ilan Matok

6 July, 2021

In recent years, the use of medical cannabis to treat sick kids is on the rise, although questions remain about the benefits and safety of such treatments.  Now, a team of researchers from the Hebrew University of Jerusalem (HU) has completed a first-ever meta-analysis of pediatric patients treated with medical cannabis to better understand the risks and benefits of cannabis use among young patients
 

Research projects were awarded funding by the Israel Science Foundation and Scopus BioPharma Israel Ltd.

12 August, 2018

 

Congratulations to our researchers who were awarded funding by the Israel Science Foundation:

  1. Joseph Tam - Deciphering the Crosstalk between CB1 and GLUT2 in the Development of Diabetic Nephropathy
  2. Dmitry Tsvelikhovsky - Stretching the Model of TRPV1 Activation

 

Congratulations to our researchers who were awarded funding by Scopus BioPharma Israel Ltd:

2 research projects were awarded funding by Integra Holdings

22 April, 2018

 

Congratulations to our researchers:

  1. Avi Priel & Masha Niv - Towards novel migraine drugs: activation of the pain receptor TRPA1 by cannabinoids
  2. Joseph Tam, Amiram Goldblum & Yuval Tabach - Discovery and Experimental Confirmation of Novel (Dual-Targeted) Peripherally Restricted CB1 Receptor Antagonists

2 research projects were awarded funding by CIITECH

5 November, 2017

 

Congratulations to our researchers:

  1. Prof. Raphael Mechoulam & Prof. Francesca Levi-Schaffer - The therapeutic benefit of cannabis for the treatment of asthma
  2. Joseph Tam - Testing the therapeutic effect of phytocannabinoids for nonalcoholic fatty liver disease

 

The 2017 Israel Medical Convention

8 August, 2017

 

The 2017 Israel Medical Convention will focus on medical cannabis. Prof. Raphael Mechoulam, Head of the MCCR Academic Committee, will give a lecture on the past and future of cannabis.

Admission is free - register at www.hadassah.org.il.

Hebrew University and the city of Jerusalem to host the 'International Conference on Cannabinoids' in 2021

27 July, 2017

Jerusalem, July 26, 2017 — The International Cannabinoid Research Society (ICRS - http://icrs.co) has chosen the Hebrew University of Jerusalem to host the International Symposium on the Cannabinoids in 2021 in Jerusalem.

The ICRS is the oldest scientific society dedicated to the research in the cannabis plant, cannabinoids, and their physiological and biochemical targets. The ICRS has nearly 400 members from all over the world. The members and guests of the ICRS gather yearly to present the ICRS Symposium.